In this study, we evaluated the putative synergistic activity of four PDE inhibitors (PDEis 5, 8, 9, and 10) with PMX against both squamous and non-squamous NSCLC cells lines with intact purinergic metabolic pathway in vitro. Here, ALDH7A1 is linked to non-small cell lung carcinoma.